JP2009534292A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534292A5
JP2009534292A5 JP2008544698A JP2008544698A JP2009534292A5 JP 2009534292 A5 JP2009534292 A5 JP 2009534292A5 JP 2008544698 A JP2008544698 A JP 2008544698A JP 2008544698 A JP2008544698 A JP 2008544698A JP 2009534292 A5 JP2009534292 A5 JP 2009534292A5
Authority
JP
Japan
Prior art keywords
moisture
measured
results
conditions
stored
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2008544698A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009534292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2007/059428 external-priority patent/WO2007126135A1/en
Publication of JP2009534292A publication Critical patent/JP2009534292A/ja
Publication of JP2009534292A5 publication Critical patent/JP2009534292A5/ja
Abandoned legal-status Critical Current

Links

JP2008544698A 2006-04-27 2007-04-26 塩酸ピオグリタゾンを有するアンジオテンシンii拮抗薬の医薬組成物 Abandoned JP2009534292A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79517906P 2006-04-27 2006-04-27
PCT/JP2007/059428 WO2007126135A1 (en) 2006-04-27 2007-04-26 Pharmaceutical composition of angiotensin ii antagonists with pioglitazone hcl

Publications (2)

Publication Number Publication Date
JP2009534292A JP2009534292A (ja) 2009-09-24
JP2009534292A5 true JP2009534292A5 (cg-RX-API-DMAC7.html) 2010-04-30

Family

ID=38328300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008544698A Abandoned JP2009534292A (ja) 2006-04-27 2007-04-26 塩酸ピオグリタゾンを有するアンジオテンシンii拮抗薬の医薬組成物

Country Status (6)

Country Link
JP (1) JP2009534292A (cg-RX-API-DMAC7.html)
AR (1) AR060663A1 (cg-RX-API-DMAC7.html)
CL (1) CL2007001195A1 (cg-RX-API-DMAC7.html)
PE (1) PE20080696A1 (cg-RX-API-DMAC7.html)
TW (1) TW200800299A (cg-RX-API-DMAC7.html)
WO (1) WO2007126135A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
CA2888059C (en) * 2007-05-08 2017-01-17 Dow Global Technologies Llc Water dispersible polymer compositions
AP2014007645A0 (en) 2011-10-21 2014-05-31 Takeda Pharmaceutical Sustained-release preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW284688B (cg-RX-API-DMAC7.html) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
EP1413315A4 (en) * 2001-08-03 2006-08-16 Takeda Pharmaceutical DRUGS WITH CONTINUOUS RELEASE
EP1799203A1 (en) * 2004-10-07 2007-06-27 Takeda Pharmaceutical Company Limited Agent for prophylaxis or treatment of metabolic syndrome

Similar Documents

Publication Publication Date Title
IL214236A0 (en) Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
EA201190092A1 (ru) Композиции с отсроченным высвобождением для перорального применения, содержащие аморфный бардоксолон метил (cddo-me)
IL233677A (en) Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition
JP2012031131A5 (cg-RX-API-DMAC7.html)
JP2010242999A5 (cg-RX-API-DMAC7.html)
WO2009063222A3 (en) Solid compositions
JP2012158592A5 (cg-RX-API-DMAC7.html)
IL234166B (en) Isoindoline compounds, a pharmaceutical composition containing it and its use in the preparation of a medicine
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
WO2011104652A3 (en) Veterinary compositions
MX2010003001A (es) Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a.
NZ734152A (en) Compounds, compositions and methods useful for cholesterol mobilisation
WO2012052169A3 (de) Partikelförmige pharmazeutische zusammensetzung mit einem opioid und einem opioid-antagonisten
JP2014024874A5 (cg-RX-API-DMAC7.html)
PT2389070E (pt) Formulações desintegráveis de carbonato de lantânio
WO2011141791A3 (en) Extended release formulations of desvenlafaxine base
IL215139A0 (en) Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
PH12014502221A1 (en) Prasugrel-containing immediate release stable oral pharmaceutical compositions
WO2015022560A8 (en) Stable pharmaceutical composition containing bisoprolol and ramipril
JP2012046484A5 (cg-RX-API-DMAC7.html)
PL2146951T3 (pl) Nowe ligandy agonistyczne receptorów RAR, zastosowanie w medycynie ludzi jak również w kosmetyce
EA201291189A1 (ru) Фармацевтическая композиция, содержащая солифенацин, и способ его получения
El-Gamal et al. Design and synthesis of 3-(3-chloro-4-substituted phenyl)-4-(pyridin-4-yl)-1Hpyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line